Unique ID issued by UMIN | UMIN000013469 |
---|---|
Receipt number | R000015724 |
Scientific Title | Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility multicenter study |
Date of disclosure of the study information | 2014/03/20 |
Last modified on | 2014/03/20 12:45:33 |
Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility multicenter study
A feasibility study using S-1 as adjuvant chemotherapy in breast cancer patients
Safety and feasibility of adjuvant chemotherapy with S-1 in Japanese breast cancer patients after primary systemic chemotherapy: a feasibility multicenter study
A feasibility study using S-1 as adjuvant chemotherapy in breast cancer patients
Japan |
(1) breast cancer with histological confirmation; (2) stage II or III breast cancer and previous standard anthracycline and/or taxane-based PSC, followed by curative surgery; (3) age 20-75 years; (4) Eastern Cooperative Oncology Group performance status 0,1; (5) adequate gastrointestinal function; (6) adequate organ function
Hematology and clinical oncology | Breast surgery |
Malignancy
NO
To evaluate S-1 as adjuvant chemotherapy in breast cancer patients after standard primary systemic chemotherapy
Safety
The primary endpoint was the percentage of the scheduled adjuvant chemotherapy completed using S-1 calculated by the Kaplan Meier method.
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
S-1
20 | years-old | <= |
75 | years-old | >= |
Male and Female
(1) breast cancer with histological confirmation; (2) stage II or III breast cancer and previous standard anthracycline and/or taxane-based PSC, followed by curative surgery; (3) age 20-75 years; (4) Eastern Cooperative Oncology Group performance status 0,1; (5) adequate gastrointestinal function; (6) adequate organ function
Patients with serious complications, a history of drug hypersensitivity, brain metastases with any symptoms, active secondary cancer, or pregnant women
40
1st name | |
Middle name | |
Last name | Toshiaki Saeki |
Saitama Medical University International Medical Center
Breast Oncology
1397-1 Yamane, Hidaka-shi, Saitama 350-1298, Japan
+81-42-984-4670
takshige@saitama-med.ac.jp
1st name | |
Middle name | |
Last name | Takashi Shigekawa |
Saitama Medical University International Medical Center
Breast Oncology
1397-1 Yamane, Hidaka-shi, Saitama 350-1298, Japan
+81-42-984-4670
t.shigekawa@gmail.com
Saitama Medical University International Medical Center
Ministry of Health, Labour and Welfare Grant-in-Aid for Scientific Research
NO
2014 | Year | 03 | Month | 20 | Day |
Unpublished
Completed
2007 | Year | 07 | Month | 30 | Day |
2007 | Year | 09 | Month | 01 | Day |
2014 | Year | 03 | Month | 20 | Day |
2014 | Year | 03 | Month | 20 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015724
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |